共 48 条
- [31] SERUM ENZYME CHANGES IN PATIENTS RECEIVING ANTITUBERCULOSIS THERAPY WITH RIFAMPICIN OR PARA-AMINOSALICYLIC ACID, PLUS ISONIAZID AND STREPTOMYCIN TUBERCLE, 1974, 55 (02): : 115 - 120
- [33] INTERMITTENT VIOMYCIN THERAPY IN PULMONARY TUBERCULOSIS - EMPLOYED SINGLY AND IN COMBINATION WITH INTERMITTENT STREPTOMYCIN OR DAILY PARA-AMINOSALICYLIC ACID DISEASES OF THE CHEST, 1953, 23 (03): : 241 - 254
- [35] CONTROL STUDY OF COMPARATIVE EFFICACY OF ISONIAZID, STREPTOMYCIN-ISONIAZID, AND STREPTOMYCIN PARA-AMINOSALICYLIC ACID IN PULMONARY TUBERCULOSIS THERAPY .4. REPORT ON 40 WEEK OBSERVATIONS ON 583 PATIENTS WITH STREPTOMYCIN-SUSCEPTIBLE INFECTIONS AMERICAN REVIEW OF TUBERCULOSIS, 1953, 68 (02): : 264 - 269
- [36] COMBINED INTERMITTENT REGIMENS EMPLOYING STREPTOMYCIN AND PARA-AMINOSALICYLIC ACID IN THE TREATMENT OF PULMONARY TUBERCULOSIS - A COMPARISON WITH DAILY AND INTERMITTENT DOSAGE SCHEDULES AMERICAN REVIEW OF TUBERCULOSIS, 1951, 63 (03): : 295 - 311
- [37] THE FREQUENCY OF DRUG-RESISTANT TUBERCLE-BACILLI FOLLOWING ADMINISTRATION OF DIHYDROSTREPTOMYCIN AND PARA-AMINOSALICYLIC ACID 3 DAYS PER WEEK PROCEEDINGS OF THE STAFF MEETINGS OF THE MAYO CLINIC, 1951, 26 (23): : 437 - 440
- [38] CONVENTIONAL THERAPY VERSUS THE CONTINUOUS AND CONCURRENT USE OF STREPTOMYCIN, ISONIAZID, AND PARA-AMINOSALICYLIC ACID PLUS EARLY SURGERY IN THE TREATMENT OF TUBERCULOSIS - 2 YEAR REPORT DISEASES OF THE CHEST, 1955, 28 (05): : 537 - 547
- [40] COMBINED DRUG TREATMENT OF TUBERCULOSIS .1. PREVENTION OF EMERGENCE OF MUTANT POPULATIONS OF TUBERCLE BACILLI RESISTANT TO BOTH STREPTOMYCIN AND ISONIAZID INVITRO JOURNAL OF CLINICAL INVESTIGATION, 1959, 38 (08): : 1349 - 1355